Hims & Hers Health (Hims & Hers Health) ROCE % : -0.47% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Hims & Hers Health ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Hims & Hers Health's annualized ROCE % for the quarter that ended in Dec. 2023 was -0.47%.

Hims & Hers Health ROCE % Historical Data

The historical data trend for Hims & Hers Health's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hims & Hers Health ROCE % Chart

Hims & Hers Health Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

-139.18

-19.55

-51.72

-20.82

-8.78

Hims & Hers Health Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial													-14.63	-14.11	-11.48	-10.45	-0.47

Hims & Hers Health ROCE % Calculation

Hims & Hers Health's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-29.453	/	( ( (366.341 - 47.941)	+	(441.186 - 88.468) )	/ 2 )
	=	-29.453	/	( (318.4	+	352.718)	/ 2 )
	=	-29.453	/	335.559
	=	-8.78 %

Hims & Hers Health's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-1.6	/	( ( (413.865 - 82.545)	+	(441.186 - 88.468) )	/ 2 )
	=	-1.6	/	( ( 331.32	+	352.718 )	/ 2 )
	=	-1.6	/	342.019
	=	-0.47 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Hims & Hers Health (NYSE:HIMS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Hims & Hers Health ROCE % Related Terms

Thank you for viewing the detailed overview of Hims & Hers Health's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hims & Hers Health (Hims & Hers Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Hims & Hers Health Inc (NYSE:HIMS) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

82W:Germany

Address

2269 Chestnut Street, Suite 523, San Francisco, CA, USA, 94123

Website

https://www.forhims.com

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.

Executives

Andrew Dudum	director, 10 percent owner, officer: Chief Executive Officer	2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Oluyemi Okupe	officer: Chief Financial Officer	2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Soleil Boughton	officer: See Remarks	2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Lynne Chou O'keefe	director	2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Irene Becklund	officer: Interim PFO/PAO	2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Melissa Baird	officer: Chief Operating Officer	2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
David B Wells	director	C/O NETFLIX, INC., 100 WINCHESTER CIRCLE, LOS GATOS CA 95130
Alex Bard	director	2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Ivp Executive Fund Xvi, Llc	10 percent owner	3000 SAND HILL ROAD, BUILDING 2, SUITE 2, MENLO PARK CA 94025
Jules A. Maltz	director	3000 SAND HILL ROAD, BUILDING 2, SUITE 250, MENLO PARK CA 94025
Christiane Pendarvis	director	2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Michael Chi	officer: Chief Marketing Officer	2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Somesh Dash	10 percent owner	3000 SAND HILL ROAD, BUILDING 2, SUITE 250, MENLO PARK CA 94025
Jack Abraham	10 percent owner	1 LETTERMAN DRIVE, SUITE C3500, SAN FRANCISCO CA 94129
Patrick Harrison Carroll	officer: Chief Medicall Officer	2269 CHESTNUT STREET, # 523, SAN FRANCISCO CA 94123